SeaStar Medical (NASDAQ:ICU) Posts Quarterly Earnings Results

SeaStar Medical (NASDAQ:ICU) released its earnings results on Thursday. The company reported ($0.90) earnings per share (EPS) for the quarter, Zacks reports.

SeaStar Medical Price Performance

NASDAQ:ICU traded down $0.23 on Thursday, hitting $2.20. 346,037 shares of the company’s stock were exchanged, compared to its average volume of 250,313. The company has a market cap of $14.24 million, a P/E ratio of -0.19 and a beta of -0.97. SeaStar Medical has a 52 week low of $1.50 and a 52 week high of $20.70. The firm has a 50-day moving average price of $1.86 and a 200-day moving average price of $2.65.

About SeaStar Medical

SeaStar Medical Holding Corporation, a medical device company, develops a platform therapy to reduce the consequences of hyperinflammation on vital organs in the United States. The company offers inflammatory response to fend off infections and repair damaged tissue in the body. It is also developing products in various therapeutic areas, including pediatric and adult acute kidney injury on CRRT; cardiorenal syndrome in congestive heart failure; myocardial stunning in end stage renal disease; and hepatorenal syndrome.